Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;7(8):1234-41.
doi: 10.2215/CJN.01150112. Epub 2012 May 17.

Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic

Affiliations

Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic

Pantelis A Sarafidis et al. Clin J Am Soc Nephrol. 2012 Aug.

Abstract

Background and objectives: Recent studies evaluated the prevalence of hyperkalemia and related risk factors in patients with CKD of various stages, but there is limited relevant information in predialysis patients. This study aimed to examine the prevalence and factors associated with hyperkalemia in the structured environment of a low-clearance clinic.

Design, setting, participants, & measurements: In a cross-sectional fashion over a prespecified period of 4 months, information on serum potassium and relevant laboratory variables, comorbidities, medications, and dietician input in patients with advanced CKD under follow-up in the low-clearance clinic of our department was recorded. Univariate and multiple logistic regression analyses were used to identify factors associated with serum potassium ≥ 5.5 meq/L.

Results: The study population consisted of 238 patients aged 66.2 ± 4.2 years with estimated GFR of 14.5 ± 4.8 ml/min per 1.73 m(2). The prevalence of hyperkalemia. defined as potassium > 5.0, ≥ 5.5, and ≥ 6.0 meq/L., was at 54.2%, 31.5%, and 8.4%, respectively. In univariate comparisons, patients with potassium ≥ 5.5 meq/L had significantly higher urea and lower estimated GFR and serum bicarbonate; also, they were more often using sodium bicarbonate and had received potassium education and attempts for dietary potassium lowering. Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers was not associated with hyperkalemia. In multivariate analyses, estimated GFR<15 ml/min per 1.73 m(2) and sodium bicarbonate use were independently associated with hyperkalemia.

Conclusions: The prevalence of hyperkalemia in predialysis patients with CKD is high. Even at this range of renal function, low estimated GFR seems to be the most important factor associated with hyperkalemia among the wide range of demographic, clinical, and laboratory characteristics studied.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Distribution of serum potassium levels in the study population.

Comment in

  • Hyperkalemia in predialysis patients.
    Palmer BF. Palmer BF. Clin J Am Soc Nephrol. 2012 Aug;7(8):1201-2. doi: 10.2215/CJN.06060612. Epub 2012 Jul 5. Clin J Am Soc Nephrol. 2012. PMID: 22773593 No abstract available.

References

    1. Allon M: Hyperkalemia in end-stage renal disease: Mechanisms and management. J Am Soc Nephrol 6: 1134–1142, 1995 - PubMed
    1. Acker CG, Johnson JP, Palevsky PM, Greenberg A: Hyperkalemia in hospitalized patients: Causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 158: 917–924, 1998 - PubMed
    1. Weiner ID, Wingo CS: Hyperkalemia: A potential silent killer. J Am Soc Nephrol 9: 1535–1543, 1998 - PubMed
    1. Perazella MA: Drug-induced hyperkalemia: Old culprits and new offenders. Am J Med 109: 307–314, 2000 - PubMed
    1. Palmer BF: A physiologic-based approach to the evaluation of a patient with hyperkalemia. Am J Kidney Dis 56: 387–393, 2010 - PubMed

MeSH terms